ArticlePharmaceutics2023

Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation.

Dibyalochan Mohanty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.